Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bulent Cetin

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Current Urology|November 27, 2019
The Potential for Chemotherapy-Free Strategies in Advanced Prostate CancerBulent Cetin, Ahmet Ozet
The New England Journal of Medicine|August 30, 2023
PD-1 and PD-L1 Blockade plus Chemotherapy in Endometrial CancerBulent Cetin, Ozge Gumusay
International Urology and Nephrology|August 31, 2019
Game of thrones: immunotherapy versus molecular targeted therapy in renal cell cancer scenariosBulent Cetin, Alim Kosar
Translational Gastroenterology and Hepatology|February 1, 2017
<i>HER2/neu</i> as target in gastric adenocarcinomaBulent Cetin, Ahmet Ozet
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 9, 2021
Understanding relevant immune mechanisms in gastrointestinal oncologyBulent Cetin, Ozge Gumusay
The New England Journal of Medicine|June 25, 2020
Pembrolizumab for Early Triple-Negative Breast CancerBulent Cetin, Ozge Gumusay
Cell|October 5, 2010
How to survive aneuploidyBulent Cetin, Don W Cleveland
Cancer Chemotherapy and Pharmacology|January 22, 2026
First-in-class HIF-2α therapy in genitourinary oncology: Belzutifan from von Hippel-Lindau disease to advanced renal cell carcinomaIrem Karaman, Dilek Erdem, Bulent Cetin
Asian Journal of Psychiatry|May 29, 2020
Can you draw the picture of happiness- Treatment of a young woman with breast cancer during the COVID-19 pandemicBulent Cetin, Sema Rakici, Ozge Gumusay
The American Journal of the Medical Sciences|September 3, 2017
Retinal Metastases From Anaplastic AstrocytomaOnur Gokmen, Bulent Cetin, Senem Senturk
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Current Urology|November 27, 2019
The Potential for Chemotherapy-Free Strategies in Advanced Prostate CancerBulent Cetin, Ahmet Ozet
The New England Journal of Medicine|August 30, 2023
PD-1 and PD-L1 Blockade plus Chemotherapy in Endometrial CancerBulent Cetin, Ozge Gumusay
International Urology and Nephrology|August 31, 2019
Game of thrones: immunotherapy versus molecular targeted therapy in renal cell cancer scenariosBulent Cetin, Alim Kosar
Translational Gastroenterology and Hepatology|February 1, 2017
<i>HER2/neu</i> as target in gastric adenocarcinomaBulent Cetin, Ahmet Ozet
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 9, 2021
Understanding relevant immune mechanisms in gastrointestinal oncologyBulent Cetin, Ozge Gumusay
The New England Journal of Medicine|June 25, 2020
Pembrolizumab for Early Triple-Negative Breast CancerBulent Cetin, Ozge Gumusay
Cell|October 5, 2010
How to survive aneuploidyBulent Cetin, Don W Cleveland
Cancer Chemotherapy and Pharmacology|January 22, 2026
First-in-class HIF-2α therapy in genitourinary oncology: Belzutifan from von Hippel-Lindau disease to advanced renal cell carcinomaIrem Karaman, Dilek Erdem, Bulent Cetin
Asian Journal of Psychiatry|May 29, 2020
Can you draw the picture of happiness- Treatment of a young woman with breast cancer during the COVID-19 pandemicBulent Cetin, Sema Rakici, Ozge Gumusay
The American Journal of the Medical Sciences|September 3, 2017
Retinal Metastases From Anaplastic AstrocytomaOnur Gokmen, Bulent Cetin, Senem Senturk
Pageof 8